[1]
|
Dall’Asta, A., Gizzo, S., Musaro, A., et al. (2014) Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP): Pathology, Follow-Up and Recurrence. International Journal of Clinical and Experimental Pathology, 7, 8136-8142.
|
[2]
|
Bell, S.W., Kempson, R.L. and Hendrickson, M.R. (1994) Problematic Uterine Smooth Muscle Neoplasms. The American Journal of Surgical Pathology, 18, 535-558. https://doi.org/10.1097/00000478-199406000-00001
|
[3]
|
Gupta, M., Laury, A.L., Nucci, M.R. and Quade, B.J. (2018) Predictors of Adverse Outcome in Uterine Smooth Muscle Tumours of Uncertain Malignant Potential (STUMP): A Clinicopathological Analysis of 22 Cases with a Proposal for the Inclusion of Additional Histological Parameters. Histopathology, 73, 284-298. https://doi.org/10.1111/his.13515
|
[4]
|
Ferrandina, G., Aristei, C., Biondetti, P.R., Cananzi, F.C.M., Casali, P., Ciccarone, F., et al. (2020) Italian Consensus Conference on Management of Uterine Sarcomas on Behalf of S.I.G.O. (Societa’ italiana di Ginecologia E Ostetricia). European Journal of Cancer, 139, 149-168. https://doi.org/10.1016/j.ejca.2020.08.016
|
[5]
|
Huo, L., Wang, D., Wang, W., Cao, D., Yang, J., Wu, M., et al. (2020) Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases. Frontiers in Oncology, 10, Article 647. https://doi.org/10.3389/fonc.2020.00647
|
[6]
|
Akad, F., Filip, B., Mocanu, V., et al. (2021) Rare Case of Smooth Muscle Tumor of Uncertain Malignant Potential—Clinical Case. Maedica, 16, 302-306.
|
[7]
|
Jeon, J., Park, J., Lee, E., Han, J., Kim, D., Park, J., et al. (2023) Prolapsed Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Case Report and Review of Radiological Findings. Current Medical Imaging, 20, Article ID: e140623217957. https://doi.org/10.2174/1573405620666230614093128
|
[8]
|
Lapresa-Alcalde, M.V., Ruiz-Navarro, M.J., Sancho de Salas, M. and Cubo, A.M. (2023) A Review and Follow-Up of Uterine Smooth Muscle Tumours of Uncertain Malignant Potential (STUMP): A Case Series and Literature Review. Diseases, 11, Article 99. https://doi.org/10.3390/diseases11030099
|
[9]
|
Rubisz, P., Ciebiera, M., Hirnle, L., Zgliczyńska, M., Łoziński, T., Dzięgiel, P., et al. (2019) The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium. International Journal of Molecular Sciences, 20, Article 1136. https://doi.org/10.3390/ijms20051136
|
[10]
|
Kobayashi, H., Uekuri, C., Akasaka, J., Ito, F., Shigemitsu, A., Koike, N., et al. (2013) The Biology of Uterine Sarcomas: A Review and Update. Molecular and Clinical Oncology, 1, 599-609. https://doi.org/10.3892/mco.2013.124
|
[11]
|
Travaglino, A., Raffone, A., Gencarelli, A., Neola, D., Oliviero, D.A., Alfano, R., et al. (2021) p53, p16 and ki67 as Immunohistochemical Prognostic Markers in Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP). Pathology-Research and Practice, 226, Article 153592. https://doi.org/10.1016/j.prp.2021.153592
|
[12]
|
Rizzo, A., Ricci, A.D., Saponara, M., De Leo, A., Perrone, A.M., De Iaco, P., et al. (2020) Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of the Art. Anticancer Research, 40, 1229-1238. https://doi.org/10.21873/anticanres.14064
|
[13]
|
Reed, J.C., et al. (1991) Mitochondrial Protein p26 BCL2 Reduces Growth Factor Requirements of NIH3T3 Fibroblasts. Experimental Cell Research, 195, 277-283. https://doi.org/10.1016/0014-4827(91)90374-4
|
[14]
|
Mowers, E.L., Skinner, B., McLean, K. and Reynolds, R.K. (2015) Effects of Morcellation of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential and Endometrial Stromal Sarcoma: Case Series and Recommendations for Clinical Practice. Journal of Minimally Invasive Gynecology, 22, 601-606. https://doi.org/10.1016/j.jmig.2015.01.007
|
[15]
|
Zhang, R., Tian, X., Qin, L., Lu, D. and Shen, J. (2015) High 18F-FDG Uptake for Uterine Smooth Muscle Tumor of Uncertain Malignant Potential. Clinical Nuclear Medicine, 40, 349-351. https://doi.org/10.1097/rlu.0000000000000727
|
[16]
|
Ho, K.-C., Dean Fang, Y.-H., Lin, G., Ueng, S.-H., Wu, T.-I., Lai, C.-H., et al. (2018) Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans. Contrast Media & Molecular Imaging, 2018, Article 7890241. https://doi.org/10.1155/2018/7890241
|
[17]
|
Guntupalli, S.R., Ramirez, P.T., Anderson, M.L., Milam, M.R., Bodurka, D.C. and Malpica, A. (2009) Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Retrospective Analysis. Gynecologic Oncology, 113, 324-326. https://doi.org/10.1016/j.ygyno.2009.02.020
|
[18]
|
Basaran, D., Usubutun, A., Salman, M.C., Narin, M.A., Boyraz, G., Turkmen, O., et al. (2018) The Clinicopathological Study of 21 Cases with Uterine Smooth Muscle Tumors of Uncertain Malignant Potential. International Journal of Gynecological Cancer, 28, 233-240. https://doi.org/10.1097/igc.0000000000001178
|
[19]
|
Ly, A., Mills, A.M., McKenney, J.K., Balzer, B.L., Kempson, R.L., Hendrickson, M.R., et al. (2013) Atypical Leiomyomas of the Uterus. American Journal of Surgical Pathology, 37, 643-649. https://doi.org/10.1097/pas.0b013e3182893f36
|
[20]
|
Peeters, N., Hulsbosch, S., Ballaux, F. and Baekelandt, J. (2016) Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Analysis of Diagnoses and Therapies Illustrated by Two Case Reports. European Journal of Gynaecological Oncology, 37, 367-373.
|
[21]
|
Vilos, G.A., Marks, J., Ettler, H.C., Vilos, A.G., Prefontaine, M. and Abu-Rafea, B. (2012) Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Diagnostic Challenges and Therapeutic Dilemmas. Report of 2 Cases and Review of the Literature. Journal of Minimally Invasive Gynecology, 19, 288-295. https://doi.org/10.1016/j.jmig.2011.12.025
|